S03 Ep. 30 NMIBC Tumor Board: Nuances in Management with Dr. Mark Tyson and Dr. Sarah Psutka

07/10/2025 29 min
S03 Ep. 30 NMIBC Tumor Board: Nuances in Management with Dr. Mark Tyson and Dr. Sarah Psutka

Listen "S03 Ep. 30 NMIBC Tumor Board: Nuances in Management with Dr. Mark Tyson and Dr. Sarah Psutka"

Episode Synopsis

When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern treatments, biomarkers, and clinical studies have opened up new avenues for treating recurrent non-muscle invasive bladder cancer (NMIBC). The penultimate episode of the 2025 NMIBC Creator Weekend™ series features urologic oncologists Dr. Vignesh Packiam, Dr. Mark Tyson, and Dr. Sarah Psutka discussing how they navigate complex bladder cancer scenarios.

---

This podcast is supported by an educational grant from Ferring Pharmaceuticals.

---

SYNPOSIS

The doctors share treatment strategies, staging processes, and post-therapy patient management techniques. They address recurrent disease, approaches to different stages of cancer, the role of biomarkers in determining treatment paths, and considerations for both high-risk and intermediate-risk patients. Additionally, the episode touches on new treatments, clinical trials, and patient quality of life post-treatment.

---

TIMESTAMPS

00:00 - Introduction02:08 - Case Study: Initial Patient Assessment04:59 - Surgical Considerations and Techniques10:22 - Managing Bladder Cancer Recurrence11:15 - Treatment Options and Clinical Trials15:12 - Advanced Treatment Strategies28:14 - Closing Remarks and Credits

More episodes of the podcast BackTable Tumor Board